Evidence map›Paper›PMID 38356582›Full record

ArticleHeliyon2024

Enhanced antimicrobial efficacy of biogenic ZnO nanoparticles through UV-B activation: A novel approach for textile garment.

David Asmat-Campos, Jesús Rojas-Jaimes, Marco Simbrón de la Cruz, Gabriela Montes de Oca-Vásquez

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

David Asmat-CamposDirección de Investigación, Innovación & Responsabilidad Social, Universidad Privada del Norte, Peru.
Jesús Rojas-JaimesDirección de Investigación, Innovación & Responsabilidad Social, Universidad Privada del Norte, Peru.
Marco Simbrón de la CruzEscuela de Farmacia y Bioquímica, Universidad Privada Norbert Wiener, Lima, Peru.
Gabriela Montes de Oca-VásquezNational Laboratory of Nanotechnology, National Center for High Technology, Pavas, San José, 10109, Costa Rica.
Private University of the North · PECentro Nacional de Alta TecnologíaUniversidad Norbert Wiener · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc oxide nanoparticles (ZnO NP) are characterized by novel properties which have been attracting the attention of different lines of research due to their wide applicability. Obtaining this nanomaterial is strongly linked to biogenic synthesis methods, which have also been developed in this research, using

Indexed as

SanitizationUV disinfectionUV photoactivationZnO nanoparticles

Identifiers

PMID38356582
PMCPMC10864978
OpenAlexW4391533070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.